Global Analgesics Market 2016-2020

Global Analgesics Market 2016-2020

  • June 2016 •
  • 102 pages •
  • Report ID: 3938311 •
  • Format: PDF
About the Analgesics Market

Analgesics are among the most commonly prescribed drugs for pain, especially that from fractures, ankle sprains, and other injuries. These are designed particularly for pain relief. Opioids, NSAIDs, and local anesthetics are the major analgesics used to treat pain. The long term use of analgesics has been linked to gastrointestinal problems. Pain is treated with analgesics, also called as pain killers, many of which are accessible without a prescription, including acetaminophen, aspirin, or ibuprofen. These medicines are termed as non-prescription or OTC analgesics and can be used either alone for mild pain or in combination with other medicines for severe pain.

Technavio’s analysts forecast the global analgesics market to grow at a CAGR of 4.28% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global analgesics market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the total consumption of analgesics globally. The report does not include revenue generated from the aftermarket service of the product.


The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Analgesics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
- Pfizer
- Bayer HealthCare
- Sanofi
- Endo
- Johnson & Johnson
- Purdue Pharma


Other prominent vendors
- Achelios Therapeutics
- Alder BioPharmaceuticals
- Allergan
- Amgen
- AstraZeneca
- Baxter
- Boehringer Ingelheim
- Bristol Myers Squibb
- CoLucid Pharmaceuticals
- Daiichi Sankyo
- Dr. Reddy's Laboratories
- DURECT
- El Lilly & Company
- F. Hoffmann La Roche
- GlaxoSmithKline
- GW Pharmaceuticals
- Hospira
- Immune Pharmaceuticals
- Innovative Med Concepts
- Merck
- NeurAxon
- Novartis
- OptiNose
- Pain Therapeutics
- RedHill
- Sorrento Therapeutics
- Suda
- Taro Pharmaceuticals Industries
- Teva Pharmaceuticals Industries
- Tonix Pharmaceuticals
- Trigemina
- UCB
- Valeant Pharmaceuticals International
- WEX Pharmaceuticals
- Zynerba Pharmaceuticals

Market driver
- Increase in self-medication
- For a full, detailed list, view our report

Market challenge
- Preference for alternative therapies
- For a full, detailed list, view our report

Market trend
- Accelerated use of online resources
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.



Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.